Categories
Change Password!
Reset Password!
Intranasal mometasone furoate is a beneficial therapeutic choice for the management of non-allergic rhinitis.
An observational, prospective study conducted in Italy has shed light on the effectiveness of intranasal mometasone furoate as a treatment for non-allergic rhinitis (NAR). Treatment with 200 µg twice a day mometasone furoate for fifteen consecutive days per month for six consecutive months, along with isotonic nasal saline, remarkably enhanced olfactory function and quality of life (QoL) in an Italian population of patients with NAR and NAR with neutrophils as the most frequent cytological pattern.
In this real-life study, researchers aimed to evaluate the impact of mometasone furoate on 31 patients (between the ages of 18 and 64 years) suffering from NAR. They received intranasal mometasone furoate at a dosage of 200 µg twice a day for fifteen consecutive days per month over a span of six consecutive months. In addition to mometasone furoate, participants were also administered isotonic nasal saline. Several key parameters were evaluated both at the study's outset and after the treatment period. These parameters included:
The study identified that NAR with neutrophils was the most predominant cytological pattern, affecting 48% of the total sample. Importantly, the therapeutic response to intranasal mometasone furoate was positive. Patients experienced an improvement in their olfactory function and reported an overall enhancement in their quality of life.
In conclusion, this study underscores the effectiveness of intranasal mometasone furoate as a treatment option for patients suffering from NAR. These findings provide valuable insights into the management of NAR and offer a promising avenue for improving the lives of individuals affected by this condition. Further research and clinical studies may help refine the treatment approaches for NAR, ultimately benefiting patients with this condition.
Journal of Personalized Medicine
Mometasone Furoate in Non-Allergic Rhinitis: A Real-Life Italian Study
Angela Rizzi et al.
Comments (0)